SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-099945
Filing Date
2022-09-14
Accepted
2022-09-14 12:19:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2225855d1_424b5.htm 424B5 1000396
2 GRAPHIC tm228846d1_424b5sp1img001.jpg GRAPHIC 14780
  Complete submission text file 0001104659-22-099945.txt   1022084
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B5 | Act: 33 | File No.: 333-251673 | Film No.: 221242495
SIC: 2834 Pharmaceutical Preparations